Sheila Jacobs is a journalist whose work has appeared in various medical publications, including Psychiatry Advisor, Pulmonology Advisor, Rheumatology Advisor, and Neurology Advisor. She covers a range of topics in the medical field, including respiratory health, genetic testing, and treatment options for various conditions.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Sheila Jacob's coverage primarily focuses on medical research, with a strong emphasis on citing data. Given this focus, she is likely to be most responsive to pitches that offer access to new and significant scientific findings in the fields of medical research and healthcare.
As her articles are heavily reliant on data, sources or experts who can provide robust scientific evidence or insights from clinical studies would likely capture her attention. Pitches offering exclusive access to researchers involved in groundbreaking studies related to Prader-Willi Syndrome, Cystic Fibrosis, Alpha-1 Antitrypsin Deficiency, and Idiopathic Pulmonary Fibrosis may also be well-received.
While there is no specified geographic focus for Sheila's work, it’s clear that she has a broad interest in impactful medical research regardless of location.
This information evolves through artificial intelligence and human feedback. Improve this profile .
| Immunosuppressive therapy (IST) in combination with eltrombopag can improve the hematologic recovery of patients with severe aplastic
| The use of Hsp110/sGC dual-target modulators has been shown to be beneficial in the treatment of pulmonary arterial hypertension (PAH), according to findings from a study published in the Journal of Medicinal Chemistry
| Focusing on the early diagnosis of hemolytic disease of the fetus and newborn (HDFN), including the use of serologic and molecular
| A positive benefit-to-risk profile has been reported in patients with transthyretin amyloid polyneuropathy (ATTR-PN) who are switched from
| In patients with acquired hemophilia A, the complete elimination of inhibitors necessitates the use of prolonged immunosuppressive
| The implementation of consensus recommendations and criteria for individuals with primary biliary cholangitis (PBC) can enhance patient
| The transferrin receptor (TFRC) has been recognized as a potential biomarker for the diagnosis and treatment of patients with pulmonary
Which of the statements below about the risk factors for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) are correct?
| The exploration of erythrocyte surface antigens other than those from the Rhesus (Rh) blood group system as being the cause of hemolytic
| In patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) at high risk for lung cancer, the judicious use
(833) 317-6278 
